GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Perrigo Co PLC (BSP:P1RG34) » Definitions » Cyclically Adjusted Price-to-FCF

Perrigo Co (BSP:P1RG34) Cyclically Adjusted Price-to-FCF : 9.55 (As of May. 15, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Perrigo Co Cyclically Adjusted Price-to-FCF?

As of today (2024-05-15), Perrigo Co's current share price is R$153.30. Perrigo Co's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was R$16.05. Perrigo Co's Cyclically Adjusted Price-to-FCF for today is 9.55.

The historical rank and industry rank for Perrigo Co's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

BSP:P1RG34' s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 7.5   Med: 16.14   Max: 71.03
Current: 8.99

During the past years, Perrigo Co's highest Cyclically Adjusted Price-to-FCF was 71.03. The lowest was 7.50. And the median was 16.14.

BSP:P1RG34's Cyclically Adjusted Price-to-FCF is ranked better than
90.83% of 327 companies
in the Drug Manufacturers industry
Industry Median: 33.34 vs BSP:P1RG34: 8.99

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Perrigo Co's adjusted free cash flow per share data for the three months ended in Mar. 2024 was R$-0.959. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is R$16.05 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Perrigo Co Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Perrigo Co's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Perrigo Co Cyclically Adjusted Price-to-FCF Chart

Perrigo Co Annual Data
Trend Jun14 Jun15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 13.51 11.53 10.53 9.35 9.17

Perrigo Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.09 9.78 9.14 9.17 9.56

Competitive Comparison of Perrigo Co's Cyclically Adjusted Price-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Perrigo Co's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Perrigo Co's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Perrigo Co's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Perrigo Co's Cyclically Adjusted Price-to-FCF falls into.



Perrigo Co Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Perrigo Co's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=153.30/16.05
=9.55

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Perrigo Co's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Perrigo Co's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.959/120.1096*120.1096
=-0.959

Current CPI (Mar. 2024) = 120.1096.

Perrigo Co Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 3.009 100.773 3.586
201409 2.842 100.474 3.397
201412 4.950 99.576 5.971
201503 5.268 99.975 6.329
201506 1.324 100.573 1.581
201509 2.588 100.274 3.100
201512 3.960 99.676 4.772
201603 3.502 99.676 4.220
201606 0.885 101.072 1.052
201609 4.347 100.274 5.207
201612 4.312 99.676 5.196
201703 3.757 100.374 4.496
201706 1.739 100.673 2.075
201709 3.950 100.474 4.722
201712 4.258 100.075 5.110
201803 3.687 100.573 4.403
201806 1.697 101.072 2.017
201809 3.603 101.371 4.269
201812 4.234 100.773 5.046
201903 2.070 101.670 2.445
201906 0.853 102.168 1.003
201909 3.144 102.268 3.693
201912 1.263 102.068 1.486
202003 4.911 102.367 5.762
202006 9.984 101.769 11.783
202009 0.742 101.072 0.882
202012 1.672 101.072 1.987
202103 -1.892 102.367 -2.220
202106 -3.963 103.364 -4.605
202109 11.907 104.859 13.639
202112 -6.212 106.653 -6.996
202203 2.184 109.245 2.401
202206 -1.699 112.734 -1.810
202209 1.476 113.431 1.563
202212 6.207 115.425 6.459
202303 -0.147 117.618 -0.150
202306 1.169 119.611 1.174
202309 3.344 120.708 3.327
202312 6.576 120.110 6.576
202403 -0.959 120.110 -0.959

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Perrigo Co  (BSP:P1RG34) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Perrigo Co Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Perrigo Co's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Perrigo Co (BSP:P1RG34) Business Description

Industry
Traded in Other Exchanges
Address
The Sharp Building, Hogan Place, Dublin, IRL, D02 TY74
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.

Perrigo Co (BSP:P1RG34) Headlines

No Headlines